Differentiation therapy in poor risk myeloid malignancies: Results of a dose finding study of the combination bryostatin-1 and GM-CSF

B. Douglas Smith, Richard J. Jones, Eunpi Cho, Jeanne Kowalski, Judith E. Karp, Steven D. Gore, Milada Vala, Brooke Meade, Sharyn D. Baker, Ming Zhao, Steven Piantadosi, Zhe Zhang, Gideon Blumenthal, Erica D Warlick, Robert A. Brodsky, Anthony Murgo, Michelle A. Rudek, William H. Matsui

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Differentiation therapy in poor risk myeloid malignancies: Results of a dose finding study of the combination bryostatin-1 and GM-CSF'. Together they form a unique fingerprint.

Medicine & Life Sciences